Truist Securities Maintains Buy on SI-BONE, Raises Price Target to $25
10/14/2026
Impact: 75
Healthcare
Truist Securities analyst Richard Newitter has maintained a Buy rating on SI-BONE (NASDAQ: SIBN) and increased the price target from $23 to $25. This adjustment reflects a positive outlook for the company's stock performance.
AI summary, not financial advice
Share: